Geode Capital Management’s Translational Development Acquisition Corp TDAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$177K Hold
16,554
﹤0.01% 3956
2026
Q1
$175K Hold
16,554
﹤0.01% 3959
2025
Q4
$174K Hold
16,554
﹤0.01% 3954
2025
Q3
$171K Hold
16,554
﹤0.01% 3972
2025
Q2
$171K Buy
16,554
+68
+0.4% +$691 ﹤0.01% 3926
2025
Q1
$166K Buy
+16,486
New +$166K ﹤0.01% 3898

Other funds holding TDAC

Geode Capital Management's TDAC Position: Q2 2026 in Review

Geode Capital Management held its Translational Development Acquisition Corp (TDAC) position steady in Q2 2026 at 16,554 shares worth $177K. The position accounts for ﹤0.01% of the portfolio, ranked #3956.

Geode Capital Management first reported a position in TDAC in Q1 2025 and has held it in 6 quarters since. 29 funds tracked by Wall St. Rank hold TDAC as of Q2 2026.

  • Geode Capital Management held 16,554 shares of Translational Development Acquisition Corp worth $177K as of Q2 2026.
  • Geode Capital Management left its Translational Development Acquisition Corp share count unchanged in Q2 2026.
  • Translational Development Acquisition Corp made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #3956 holding.
  • Geode Capital Management first reported a position in Translational Development Acquisition Corp in Q1 2025 and has held it in 6 quarters since.
  • 29 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.